-
Product Insights
Altus Realty/ RMI – The Warring Mixed-Use Development – Washington
Equip yourself with the essential tools needed to make informed and profitable decisions with our Altus Realty/ RMI - The Warring Mixed-Use Development - Washington report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Altus Renews/ Mitsui & Co Australia – Green Triangle Wood Pellet Plant – South Australia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Altus Renews/ Mitsui & Co Australia - Green Triangle Wood Pellet Plant - South Australia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
Altus Strategies – Diba Gold Mine – Kayes
Equip yourself with the essential tools needed to make informed and profitable decisions with our Altus Strategies - Diba Gold Mine - Kayes report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Company Profile
![]()
Altus Group Ltd – Company Profile
Altus Group Ltd (Altus) is a provider of software solutions. It offers cloud-enabled commercial real estate (CRE) software solutions. It also offers professional services including cost management, project management, development management, asset management, valuation advisory, strategic advisory and software consultancy. The company’s product portfolio includes ARGUS Enterprise, ARGUS Taliance, ARGUS Voyanta, ARGUS Developer and ARGUS EstateMaster. Altus serves various industrial sectors such as housing, healthcare, land, lodging and hospitality government and public-private partnerships and among others. The company operates across...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AFI-002 in Attention Deficit Hyperactivity Disorder (ADHD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AFI-002 in Attention Deficit Hyperactivity Disorder (ADHD) Drug Details:AFI-002 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MTB-9655 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MTB-9655 in Solid Tumor Drug Details: MTB-9655 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AFI-003 in Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AFI-003 in Pain Drug Details:AFI-003 is under development for the treatment of severe pain. The drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KRLS-004 in Renal Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.KRLS-004 in Renal Cell CarcinomaDrug Details:KRLS-004 (ASN-004) is under development for the treatment of solid tumors...
-
Company Profile
![]()
Arcelik AS – Company Profile
Arcelik AS (Arcelik), a subsidiary of Koc Holding AS, manufactures, distributes, markets, sells, exports and imports consumer electronics and consumer durables. The company's product portfolio includes washing machines, dryers, dish washers, refrigerators, ovens, cookers, air conditioners, televisions, computers, ventilators, air humidifiers, hair dryers, kitchen gadgets, vacuum cleaners, deep freezers, hoods, water heaters, and stoves. Arcelik markets its products under Arcelik, Beko, Blomberg, Arctic, Grundig, Altus, Flavel, Leisure, Defy, Dawlance, Elektrabregenz, and Voltas Beko brand names. The company operates production facilities...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lenalidomide in Relapsed Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lenalidomide in Relapsed Multiple Myeloma Drug Details: Lenalidomide (Revlimid) is a thalidomide analogue and...
-
Product Insights
Altus Spine, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Altus Spine, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are private...
-
Product Insights
Neurosurgical Products Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurosurgical Products Pipeline Market Report Overview The neurosurgical products pipeline market research report provides comprehensive information about the neurosurgical products pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Dura Substitutes ·      Neuroendoscopes ·      Neurosurgical Drills ·      Synthetic Dura Substitutes ·      Neurosurgical Drills ·      Biological Dura Substitutes Key Territories ·      The US ·      Europe ·      Canada ·      Israel ·      Japan ·      Philippines...
-
Product Insights
Blackstone Community Solar PV Park
Blackstone Community solar PV Park is a 35MW solar PV power project located in New Jersey, United States. It is being developed by Altus Power America, Inc. The project is currently in the permitting stage. The project is owned by Altus Power America, Inc. Blackstone Community solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year,...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – AFI-003
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AFI-003 Drug Details AFI-003 is under development for the treatment of severe pain. The...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – AFI-002
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AFI-002 Drug Details AFI-002 is under development for the treatment of attention deficit hyperactivity...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – acetaminophen ER
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry acetaminophen ER Drug Details Acetaminophen extended release is under development for the treatment of...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – tramadol hydrochloride ER
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tramadol hydrochloride ER Drug Details Tramadol hydrochloride extended release is under development for the...
-
Product Insights
Diba Project
The Diba Project is a Gold project in Mali. It is currently at the prefeasibility stage. Diba Project profile includes core details such as name, commodity, ore type, stage, type, owner and equity stakes, operator, size and location, as well as key expected start date, mine life and likelihood of development. We also provide estimated counts of mobile equipment.
-
Product Insights
Altus CBRE IM Community Solar PV Park
Altus CBRE IM Community solar PV Park is a 20MW solar PV power project located in Maryland, United States. It is being developed by Altus Power Inc. The project is currently in the permitting stage. The project is owned by Altus Power Inc; CBRE Group Inc. Altus CBRE IM Community solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation,...
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics. The ADHD Drugs in Development market research report provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for ADHD, complete with analysis by stage of development, drug target, mechanism of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.